| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/06/1999 | US5892039 Piperazino derivatives as neurokinin antagonists |
| 04/06/1999 | US5892036 Process for the preparation of 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines |
| 04/06/1999 | US5892034 Process for preparing 5-substituted pyrrolo- 2,3-d!pyrimidines |
| 04/06/1999 | US5892028 17, 20-epoxy steroids |
| 04/06/1999 | US5892024 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same |
| 04/06/1999 | US5891924 Blocking protein; septic shock, host reaction |
| 04/06/1999 | US5891923 Cognition activators |
| 04/06/1999 | US5891915 Method for enhancing female sexual response and an ointment therefor |
| 04/06/1999 | US5891914 Bioactive topical siloxane compositions having enhanced performance and safety |
| 04/06/1999 | US5891913 Antiinflammatory agent |
| 04/06/1999 | US5891911 Method for reducing intraocular pressure in the mammalian eye by administration of calcium chelators |
| 04/06/1999 | US5891909 Amidinohydrazones as protease inhibitors |
| 04/06/1999 | US5891907 Stable aqueous solubilizates of carotenoids and vitamins |
| 04/06/1999 | US5891905 Methods of treatment using procyanidin antioxidants |
| 04/06/1999 | US5891904 Gastrointestinal and urogenital disorders |
| 04/06/1999 | US5891901 Substituted pyrroles |
| 04/06/1999 | US5891900 Oxopyrolo-pyrrole derivatives having thrombin inhibiting activity |
| 04/06/1999 | US5891899 Pharmaceutical xanthene compounds |
| 04/06/1999 | US5891894 2-amino oxazole derivatives; antagonists of platelet activating factor useful in treatment of asthma, inflammation, cardiovascular disorders, renal diseases, or as contraceptives |
| 04/06/1999 | US5891893 5-amino-1,2,4-oxa(or thia)diazoles; antagonists of platelet activating factor useful in treatment of asthma, allergies, inflammation, cardiovascular diseases, renal diseases, or as contraceptives |
| 04/06/1999 | US5891891 Use of imidazo 1, 2-A! pyridine-3-acetamide derivatives for the therapeutic treatment of neuropsychiatric syndromes associated with disfunction of the neural circuits of the basal ganglia |
| 04/06/1999 | US5891890 Benzamide derivatives, anti-ulcer drug, and antibacterial drug |
| 04/06/1999 | US5891887 Brain disorders |
| 04/06/1999 | US5891886 Treatment of cancers |
| 04/06/1999 | US5891885 Method for treating migraine |
| 04/06/1999 | US5891884 Use of an imidazole derivative for preventing and/or treating rhinitis |
| 04/06/1999 | US5891879 Quinazolinone-containing pharmaceutical compositions and methods for the use thereof |
| 04/06/1999 | US5891878 Enzyme inhibitors of phosphodiesterase or tumor necrosis factor |
| 04/06/1999 | US5891876 Alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (ampa); drugs that enhance these receptor currents will facilitate communication in brain networks responsible for perceptual-motor integration and higher order behaviors |
| 04/06/1999 | US5891875 Morpholinyl tachykinin receptor antagonists |
| 04/06/1999 | US5891874 Anti-viral compound |
| 04/06/1999 | US5891873 Particularly alzheimer's disease. examples include aminoguanidines and amphotericin b. |
| 04/06/1999 | US5891872 Inhibit farnesyl-protein transferase |
| 04/06/1999 | US5891871 Substituted 2,3-benzodiazepin-4-ones and the use thereof |
| 04/06/1999 | US5891868 Methods for treating postmenopausal women using ultra-low doses of estrogen |
| 04/06/1999 | US5891867 Hormonal medicaments and their use for the correction of oestrogenic deficiencies |
| 04/06/1999 | US5891866 Antitumor agents and anticarcinogenic agents |
| 04/06/1999 | US5891865 Treatment of arthritic disease induced by infectious agents |
| 04/06/1999 | US5891864 Composition comprising acridine derivative and guanosine derivative |
| 04/06/1999 | US5891863 Prevent resorption of prosthetic bone |
| 04/06/1999 | US5891862 Polyvalent polymers for the treatment of rotavirus infection |
| 04/06/1999 | US5891861 Composition and method for treating fungal disease in animals |
| 04/06/1999 | US5891860 Treatment of traveller's diarrhea |
| 04/06/1999 | US5891856 Nonmutating cells by treatment with metabolites and aminoalkylphosphorothioate |
| 04/06/1999 | US5891855 Contacting with cardiac glycoside |
| 04/06/1999 | US5891854 Moisturizers |
| 04/06/1999 | US5891853 Mixture of methylsulfonyl methane, vitamin c and glucan |
| 04/06/1999 | US5891845 Drug delivery systems utilizing liquid crystal structures |
| 04/06/1999 | US5891844 Compositions for treating IRDS and ARDS with a combination of a Glucocorticosteroid and a lung surfactant, and their use |
| 04/06/1999 | US5891735 Chemiluminescence |
| 04/06/1999 | US5891725 Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them |
| 04/06/1999 | US5891704 Method to produce high levels of methioninase |
| 04/06/1999 | US5891672 Polynucleotides encoding GTP cyclohydrolase II (ribA) |
| 04/06/1999 | US5891670 Tetracycline resistance protein |
| 04/06/1999 | US5891655 Screening low molecular weight compounds for modulation of fibroblast growth factor activity such as mitogenesis of receptor expressing cells as well as competitive binding with heparin to receptor and dimerization |
| 04/06/1999 | US5891478 Composition for sustained release of human growth hormone |
| 04/06/1999 | US5891477 Non-steroidal anti-inflammatory agents inhibition of fibrotic response to an implanted device |
| 04/06/1999 | US5891472 Topical treatment for administering nitric oxide in lipid based carriers |
| 04/06/1999 | US5891471 Mechanically working a mixture of a drug and a hydrophobic and/or hydrophilic fusible carrier in a high speed mixture so as to form agglomerates and breaking the agglomerates to give controlled release particles. |
| 04/06/1999 | US5891470 Softgel formulation containing retinol |
| 04/06/1999 | US5891464 Composition based on hydrated lipidic lamelar phases or on liposomes containing at least one derivative of labdane, or a plant extract containing it; cosmetic or pharmaceutical, particularly dermatological composition containing it |
| 04/06/1999 | US5891462 Composition for transdermal administration of an estrogen |
| 04/06/1999 | US5891461 Treating psychosis, acute mania or anxiety by applying a transdermal patch to intact skin or mucosal tissue, administering olanzapine or its acid addition salts, and a skin permeation enhancer |
| 04/06/1999 | US5891460 Method for reducing or preventing post-surgical adhesion formation using ketotifen and analogs thereof |
| 04/06/1999 | US5891459 Arginine, lysine and salts with nutrients for nitric oxide intermediates |
| 04/06/1999 | US5891457 Treating menorrhagia with silver nitrate composition |
| 04/06/1999 | US5891454 Anti-cancer drug and special tumor necrotizing agent |
| 04/06/1999 | US5891430 Diabetogene rad: a type II diabetes specific gene |
| 04/06/1999 | US5891428 Physically active antimicrobial gel for cosmetic products |
| 04/06/1999 | US5891420 Environmentally safe triancinolone acetonide aerosol formulations for oral inhalation |
| 04/06/1999 | US5891075 Hydrolysis, acetic acid |
| 04/06/1999 | CA2248838A1 An intravenous form of thalidomide for the therapy of immunological diseases |
| 04/06/1999 | CA2152794C Diarylalkyl piperidines useful as multi-drug resistant tumor agents |
| 04/06/1999 | CA2151774C Skin disinfecting formulations |
| 04/06/1999 | CA2135070C Use of guanylate cyclase inhibitors in the treatment of shock |
| 04/06/1999 | CA2077394C Substituted taxanes and pharmaceutical compositions containing them |
| 04/06/1999 | CA2075850C Polysulfate of beta-cyclodextrin derivative and process for preparing the same |
| 04/06/1999 | CA2064190C Process for preparation of an oil in water emulsion of a drug |
| 04/06/1999 | CA2061824C Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer |
| 04/06/1999 | CA2050045C Pharmaceutical, vaginal applicable preparation and a process for its preparation |
| 04/06/1999 | CA2024700C Benzoylguanidines, a process for their preaparation, their use as medicaments and medicaments containing them |
| 04/06/1999 | CA2003665C Pharmaceutical composition containing 1-[mono- or bis (trifluoromethyl)-2-pyridinyl] piperazines |
| 04/06/1999 | CA2000804C Quinolyloxazole-2-ones useful as proteinkinase c inhibitors |
| 04/06/1999 | CA1340487C Ph-neutral aqueous solutions of quinolone-carboxylic acids |
| 04/06/1999 | CA1340485C Peptide analogs and their use as haptens to elicit catalytic antibodies |
| 04/06/1999 | CA1340479C Indane derivatives, process for preparing the same, new intermediates produced, use thereof as therapeutic agents and pharmaceutical compositions containing them |
| 04/02/1999 | CA2246052A1 Novel hydroxy and polyhydroxy derivatives of coumarin, preparation thereof and antiviral action thereof |
| 04/01/1999 | WO1999015894A2 Method of identification of leads or active compounds |
| 04/01/1999 | WO1999015703A1 Inhibition of an fgf-binding protein using ribozymes |
| 04/01/1999 | WO1999015656A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 04/01/1999 | WO1999015649A2 Composition and method for enhancing paracellular transport across cell layers |
| 04/01/1999 | WO1999015648A1 Antisense oligonucleotides against thymidylate synthase |
| 04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
| 04/01/1999 | WO1999015628A1 Methods and compositions for binding hematopoietic stem cells |
| 04/01/1999 | WO1999015542A2 Linker nucleoside, and production and use of the same |
| 04/01/1999 | WO1999015535A1 Binuclear complex |
| 04/01/1999 | WO1999015530A1 Tetrazole-containing rapamycin analogs with shortened half-lives |
| 04/01/1999 | WO1999015529A1 MODULES OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 04/01/1999 | WO1999015528A1 Acidic addition salts of morphine alkaloids and the application thereof |
| 04/01/1999 | WO1999015526A2 N-5,6,7,8-tetrahydro(1,6)naphthyridine-n'-phenylurea derivatives |